Menu

Jazz Pharmaceuticals plc JAZZ

Full chart Compare
Set alert

Price alert · JAZZ

All alert types
234.76 USD +7.44 (+3.27%)

At closeNov 6, 2026, 5:35 PM EST

237.00 +2.24 +0.95%

After hours · Nov 6, 5:35 PM ET

226.12 Day range 237.76
131.16 52-week range 261.62
YTD
+38.09%
1 year
+75.13%

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $272.44MUnited States → Revenue: $3.83BExpenses → Selling, General & Admin: $1.81BExpenses → Research & Development: $782.74MExpenses → Other Operating Expenses: $947.86MExpenses → Interest Expense: $195.05MExpenses → Other Expenses: $657.96MGross Profit → Expenses: $3.76BRevenue → Gross Profit: $3.76BRevenue → Cost of Revenue: $503.30MEurope → Revenue: $341.12MNet Loss → Expenses: $356.15MOther Countries → Revenue: $94.87MIncome Tax Benefit$272.44MGross Profit$3.76BNet Loss$356.15MCost of Revenue$503.30MExpenses$4.39BSelling, General & Admin$1.81BResearch & Development$782.74MOther Operating Expenses$947.86MInterest Expense$195.05MOther Expenses$657.96MRevenue$4.27BUnited States$3.83BEurope$341.12MOther Countries$94.87M

Latest period ending Dec 31, 2025 · select a line to chart its full history

JAZZ annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.27B4.07B3.83B3.66B3.09B
3.76B3.62B3.40B3.12B2.65B
-430.24M716.63M578.58M-65.53M170.28M
-356.15M560.12M414.83M-224.06M-329.67M
-5.848.656.10-3.58-5.52
JAZZ annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.39B2.41B1.51B881.48M591.45M
11.66B12.01B11.39B10.84B12.30B
7.34B7.92B7.66B7.75B8.33B
5.41B6.15B5.77B5.80B6.14B
4.32B4.09B3.74B3.09B3.97B
JAZZ annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.36B1.40B1.09B1.27B778.51M
-1.51B-508.19M-163.06M-446.23M-5.21B
-873.38M20.52M-305.25M-529.49M3.97B
-30.59M-38.07M-23.96M-29.05M-27.64M
-1.02B906.55M624.83M290.03M-466.32M